Belcesiran is an antisense rnai oligonucleotide commercialized by Novo Nordisk, ...
Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phas...
AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in P...
PN-235 is a synthetic peptide commercialized by Johnson & Johnson, with a leadin...
Discover AbbVie Inc.'s innovative patent for an extended-release tablet to treat...
Discover how Dr. Reddy's patent for innovative pyridazine compounds offers promi...
Discover Zealand Pharma's innovative patent for GLP-1/GLP-2 dual agonist composi...
Discover how AstraZeneca's new patent revolutionizes AAV vector production with ...
The US company is part of a burgeoning artificial intelligence (AI) market in ea...
TERN-701 is a BCR-ABL tyrosine-kinase inhibitor being studied in a Phase I study...
Enhance gene expression and reduce immune responses with Selecta Biosciences' pa...
In an exclusive interview, Jaguar Health’s CEO discussed plans for the investiga...
Johnson & Johnson’s Tremfya is approved for plaque psoriasis and active psoriati...
Currently approved to treat hallucinations associated with Parkinson’s disease p...
Messages leaked by a think tank inflate cancer risk of gender-affirming hormone ...
